Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION, USP

Last updated on 2021-04-16 History
Report ID 136460
Drug Identification Number 02439409
Brand name ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Common or Proper name Ropivacaine Hydrochloride Injection, USP 10 mg/mL Ampoule 20 mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) ROPIVACAINE HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration EPIDURAL EPIDURAL
Packaging size 20 mL
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-03-26
Actual start date 2021-03-26
Estimated end date 2021-04-30
Actual end date 2021-04-15
Shortage status Resolved
Updated date 2021-04-16
Company comments Fresenius Kabi Canada Ltd. is pleased to advise that the backorder on Ropivacaine Hydrochloride Injection, USP has been resolved earlier than anticipated and the product is now available across all distribution centers.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-04-16 English Compare
v5 2021-04-15 French Compare
v4 2021-04-15 English Compare
v3 2021-03-27 English Compare
v2 2021-03-26 French Compare
v1 2021-03-26 English Compare

Showing 1 to 6 of 6